Skip to main content
. 2020 Apr 2;10(2):102–109. doi: 10.4103/ijabmr.IJABMR_270_19

Table 2a.

Clinical characteristics of respondents at the 4 study sites (n=400)

Clinical characteristic Total (n=400), n (%) Adherence level of respondents Pa

Nonadherent (n=209), n (%) Adherent (n=191), n (%)
Number of years of being on oral hypoglycemic medication since diagnosis (years)
 <1-2 87 (21.8) 35 (16.7) 52 (27.2) 0.03
 3-6 174 (43.5) 92 (44.1) 82 (42.9)
 7-10 88 (22.0) 55 (26.3) 33 (17.3)
 >10 51 (12.8) 27 (12.9) 24 (12.6)
Number of oral hypoglycemic drugs prescribed at last attendance
 1 50 (12.5) 24 (11.5) 26 (13.6) 0.198
 2 215 (53.8) 106 (50.7) 109 (57.1)
 3 135 (33.7) 79 (37.8) 56 (29.3)
Number of oral hypoglycemic drugs prescribed that were unavailable at hospital pharmacy at last attendance
 0 304 (76.0) 172 (82.3) 132 (69.1) 0.005
 1 81 (20.3) 33 (15.8) 48 (25.1)
 2 15 (3.7) 4 (1.9) 11 (5.8)
Presence of chronic comorbid condition at last attendance
 Yes 317 (79.3) 170 (81.3) 147 (77.0) 0.281
 No 83 (20.7) 39 (18.7) 44 (23.0)
Chronic comorbid condition presented with diabetes at last attendance
 Hypertension 255 (63.7) 132 (63.2) 123 (64.4) 0.338
 Diabetes neuropathy 18 (4.5) 13 (6.2) 5 (2.6)
 Hypertension + neuropathy + retinopathy 16 (4.0) 10 (4.8) 6 (3.1)
 Hypertension + neuropathy 7 (1.8) 2 (1.0) 5 (2.6)
 Other co-morbid condition 18 (4.5) 10 (4.7) 8 (2.6)
 No co-morbid condition 86 (21.5) 41 (19.6) 45 (23.6)

aP value from Chi-square